Sufentanil Injection Shortage

• • Akorn had Sufenta injection on shortage due to increased demand for the product.
  • Hikma stopped marketing sufentanil injection in October 2018.
  • Pfizer had sufentanil injection on shortage due to manufacturing delays.

• • Sufenta solution for injection, Akorn, 50 mcg/mL, 1 mL ampule, 10 count, NDC 17478-0050-01
  • Sufenta solution for injection, Akorn, 50 mcg/mL, 2 mL ampule, 10 count, NDC 17478-0050-02
  • Sufenta solution for injection, Akorn, 50 mcg/mL, 5 mL ampule, 10 count, NDC 17478-0050-05
  • Sufentanil solution for injection, Pfizer, 50 mcg/mL, 1 mL vial, 10 count, NDC 00409-3382-21
  • Sufentanil solution for injection, Pfizer, 50 mcg/mL, 2 mL vial, 10 count, NDC 00409-3382-22
  • Sufentanil solution for injection, Pfizer, 50 mcg/mL, 5 mL vial, 10 count, NDC 00409-3382-25

Estimated Resupply Dates

• • All marketed presentations are available.

Implications for Patient Care

• • ASHP has an FAQ on the injectable opioid shortage at https://www.ashp.org/Drug-Shortages/Shortage-Resources/Injectable-Opioid-Shortages-FAQ. This discusses multiple issues including inventory and pharmacy operational strategies.